Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Author(s) -
Kristian Thorlund,
P.J. Devereaux,
Jørn Wetterslev,
Gordon Guyatt,
John P. A. Ioannidis,
Lehana Thabane,
Lise Lotte Gluud,
Bodil AlsNielsen,
Christian Gluud
Publication year - 2008
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyn179
Subject(s) - spurious relationship , meta analysis , medicine , inference , medline , econometrics , statistics , computer science , mathematics , artificial intelligence , biology , biochemistry
Results from apparently conclusive meta-analyses may be false. A limited number of events from a few small trials and the associated random error may be under-recognized sources of spurious findings. The information size (IS, i.e. number of participants) required for a reliable and conclusive meta-analysis should be no less rigorous than the sample size of a single, optimally powered randomized clinical trial. If a meta-analysis is conducted before a sufficient IS is reached, it should be evaluated in a manner that accounts for the increased risk that the result might represent a chance finding (i.e. applying trial sequential monitoring boundaries).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom